Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

ROKT vs. XLV: which is better?

Bottom line

ROKT vs XLV: the short answer

ROKT (State Street(R) SPDR(R) S&P Kensho Final Frontiers ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.

XLV is cheaper at 0.08% vs 0.45% — a difference of $37 a year per $10,000 invested.

Over five years, ROKT returned +18.0% a year vs +8.1% for XLV.

Updated Nov 19, 2026

ROKT vs XLV side by side

ROKTXLV
TypeETFETF
Fund familySPDR (State Street)SPDR (State Street)
CategoryEmerging MarketsHealth Care Sector
Expense ratio0.45%0.08%
Annual cost per $10k$45$8
10-yr cost on $10k (prospectus)$567$103
Max front loadNoneNone
12b-1 fee0%0.02%
1-yr return+50.4%+14.5%
5-yr return (annualized)+18.0%+8.1%
10-yr return (annualized)—+9.8%
Best quarter+23.5%+14.5%
Worst quarter−26.6%−12.7%
Net assets (fund)$248.4M$40.6B
Number of holdings4065
Portfolio turnover6%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearROKTXLVDifference
2025+50.4%+14.5%+35.9%
2024+27.9%+2.5%+25.4%
2023+14.5%+2.0%+12.5%
2022−0.9%−2.1%+1.2%
2021+4.7%+25.9%−21.2%
2020+8.4%+13.3%−4.9%
2019+39.7%+20.7%+19.0%

Source: Fund prospectus bar charts

Holdings overlap

ROKT and XLV share none of their top holdings.

ROKT top 10

  1. State Street Global Advisors — 8.15%
  2. Ducommun Inc — 3.68%
  3. Iridium Communications Inc — 3.66%
  4. ESCO Technologies Inc — 3.51%
  5. Spire Global Inc — 3.47%
  6. HEICO Corp — 3.39%
  7. Teledyne Technologies Inc — 3.39%
  8. Moog Inc — 3.39%
  9. Hexcel Corp — 3.33%
  10. Planet Labs PBC — 3.29%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between ROKT and XLV?
ROKT (State Street(R) SPDR(R) S&P Kensho Final Frontiers ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs. XLV is cheaper at 0.08% vs 0.45% — a difference of $37 a year per $10,000 invested.
Which is cheaper, ROKT or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both ROKT and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.